Liquid Milrionone Lactate Injection

Milrionone Lactate Injection

Brand Name: Milirozin-1mg
2000.00 INR / Box (2000.00 INR + 0% GST)
  • 1 Pack Contains: 1
  • Minimum Pack Size: 100

In Stock


Buy NowBuy Now
You may save more on making online payment.

Ambica Pharma

10 Years Member Since : 10 Years 3
96.77 Response Rate
Mr Vikram K Jain
Mumbai, Maharashtra ...More Office No.22 to 25, 2nd Floor, 72/78, Chapsey Building, Ladwadi, Shamaldas Gandhi Marg, Princess Street MumbaiA a A 400A 002., Mumbai, Maharashtra, 400002, India

Open Map

View Number

Product Details

Storage InstructionsDry & Cool place
Drug TypeInjection
Physical FormLiquid
Quantity10000 Pieces
Dosage GuidelinesAs per doctor
FOB PortMUMBAI
Sample AvailableYES
CertificationsWHO-GMP
Packaging Details1X10ml
Delivery Time01 Week
Main Export Market(s)Middle East, Australia, Africa, South America, Central America, Asia, North America, Western Europe, Eastern Europe
Payment TermsCash Advance (CA), Cash in Advance (CID), Western Union, Others
Supply Ability1000 Per Day
Sample PolicyFree samples available with shipping and taxes paid by the buyer
Unit of MeasurePiece/Pieces
Unit of PriceBox/Boxes
Moq100
GSTIN0%
ReturnableNo
Brand NameMilirozin-1mg
Product Unit100Piece/Pieces
Unit TypePiece/Pieces
CurrencyINR
Packsize1
Stock Quantity300
price_typefixed

Company Details

This is to introduce ourselves as a professionally managed fast growing Pharmaceutical Company having more than Five Years of Manufacturing and Marketing experience. We are based at Mumbai in the State of Maharashtra. The Company has been accredited with ISO-9001:2008 and manufactures pharmaceutical formulations as per the guidelines of WHO. It is a (GMP Certified) Unit with total quality management and In-house Testing Laboratory. Our success is the result of focusing on our clients top priorities such as quality products, on-time delivery, competitive rates and unparalleled responsiveness. Johnlee manufactures more than 400 plus Pharmaceutical Formulation Products in the form of Tablets, Capsules, Dry syrup, Liquid Orals and Sustained Release Preparations. It is the Company constant and Company will also increasingly focus in high growth potential segments like Vaccines and Biogenetics. These new areas will add significant depth to the existing product pipeline. The proteasome has been validated as an important clinical target in cancer, and Johnlee Pharmaceuticals Pvt. Ltd. is developing next-generation proteasome inhibitors with a high degree of selectivity, with the goal of increasing therapeutic efficacy and reducing side effects.

  • BUSINESS TYPE Exporter, Manufacturer, Supplier
  • EMPLOYEE COUNT 20
  • ESTABLISHMENT 2005
  • ANNUAL TURNOVER Rs 10 Crores
  • WORKING DAYS Monday To Saturday
  • PAYMENT MODE Cash Advance (CA)
  • GST NO 27AGKPJ8183H1ZY
Explore Related Categories
Send Enquiry to Supplier
Ambica Pharma To:
People Also Viewed